What does CHLOE – Egg Quality (OQ) Module cost?
What does CHLOE – Egg Quality (OQ) Module cost?
Pricing for Fairtility's oocyte assessment add-on remains private; procurement intelligence is needed
Exact pricing for CHLOE OQ, which secures CE certification and empowers embryologists and patients with oocyte quality insights for egg freezing, egg donation and IVF applications , is not publicly listed by Fairtility. The company does not publish list prices, lease rates, or module-specific costs in regulatory filings, GSA schedules, or materials available to fertility clinics—making it impossible to quote a reliable range without direct vendor negotiation. This article is a live draft and will be updated as MedSource accumulates quote data from clinic procurement officers.
What the typical range is
No aggregate pricing data exists. Fairtility markets CHLOE as a modular software platform with variable licensing structures. Clinics report that cost depends on:
- Time-lapse incubator model (integration required)
- Annual subscription vs. perpetual license
- Number of embryologists/concurrent users
- EMR integration complexity
- Training and support tier
Informal reports from fertility clinic networks suggest module add-ons in the AI-powered medical device space run $30,000–$150,000 annually or $100,000–$300,000+ for perpetual installation; CHLOE OQ likely sits within this window as a diagnostic software module, but without published pricing, this remains speculation.
What pushes price up — features, certifications, support tier
CHLOE OQ has received CE certification , positioning it as a regulated in vitro diagnostic. Several factors increase cost:
Regulatory pathway
CHLOE is an investigational device, and portions of the software are currently pending FDA approval , meaning U.S. clinics may face additional negotiation or higher pricing during the review period. CE marking in Europe carries lower friction.
Time-lapse incubator dependency
CHLOE automatically retrieves images collected by your time-lapse system and can provide outputs via APIs into your EMR system . Clinics without compatible systems (Embryoscope, Geri, MIRI, or others with integrated micro-cameras) must budget for incubator upgrade first—a $100,000–$200,000 capital purchase.
Clinical data scope
CHLOE OQ offers IVF professionals comprehensive information to support decision making and delivers predictions of an oocyte's potential to reach the blastocyst stage post-fertilisation . Modules offering expanded analytics (per-egg viability scores, batch-level reporting, pregnancy success modeling) likely command premium licensing.
Support and integration
EMR integration via APIs, user training, and on-site validation testing add cost.
CHLOE is cloud-based and can be installed and updated remotely; Chloe is supporting any EMR that can work with the latest APIs
—but deep integration (direct HL7/FHIR mapping, custom workflow design) is not included in base licensing.
Volume and clinic size
Multi-location contracts or large labs with high cycle volume likely achieve better per-cycle pricing than single clinics.
What pushes price down — refurbished, older generation, lease, GPO contracts
Lease vs. purchase
No published information exists on lease or subscription-to-purchase pathways. Fairtility may offer monthly or annual subscriptions to reduce upfront capital burden, but this is not disclosed publicly.
GPO contracts
No evidence that CHLOE is listed under fertility-focused group purchasing organizations (GPOs) or managed care consortia. Procurement officers should inquire whether Fairtility holds contracts with ASHP, Premier, or other medical device aggregators.
Bundled incubator packages
Esco Medical offers "optional Fairtility CHLOE AI System" with "special unlimited use pricing for ESCO MIRI TL users" . Clinics purchasing the MIRI time-lapse incubator directly from Esco may negotiate CHLOE OQ inclusion at favorable rates. Similar partnerships with other incubator makers (Vitrolife Embryoscope, Cooper Geri) may exist but are not public.
Competitive alternatives
No directly comparable oocyte-assessment AI modules have reached market. CHLOE OQ is currently without published competitors offering equivalent functionality, limiting leverage for price negotiation.
Hidden costs — install, training, calibration, consumables, service contracts
Setup and validation
Automatic assessment of embryos cultured in time-lapse and direct integration between CHLOE, the time-lapse incubator and the electronic medical record (EMR) provides opportunities for automatic data-capture directly from the source . Integration time is non-trivial—expect 20–40 hours of IT and embryology staff time, plus 8–16 hours of user training.
Data infrastructure
CHLOE is cloud-based. Clinics must provide secure network connectivity, HIPAA-compliant data handling, and potentially enhanced cybersecurity (dedicated VPN, endpoint protection). Annual IT support for API maintenance is not explicitly priced but should be budgeted at $5,000–$15,000/year.
Annual software maintenance and updates
Typical SaaS models for medical software include annual maintenance at 15–20% of original license cost. If a perpetual license is $100,000, plan for $15,000–$20,000/year in updates and support.
Clinical validation on your data
Many AI tools require site-specific validation (comparison of machine output vs. embryologist assessments on historical cycles). Budget 40–60 embryo assessments for internal accuracy testing before clinical use.
No consumables
Unlike hardware modules, CHLOE OQ generates no ongoing supply costs once images are captured by your incubator.
How to negotiate — concrete tactics
-
Bundle with incubator purchase
If upgrading to a new time-lapse system, negotiate CHLOE OQ inclusion or a significant discount (15–30% off module licensing) as part of the overall capital equipment deal. Esco Medical's pricing model shows this is feasible. -
Request a multi-year contract discount
Software vendors typically offer 10–15% discounts for 3-year prepayment. Ask Fairtility for fixed annual fees locked across a 3–5 year term. -
Pilot program or proof-of-concept
Request a 90-day trial at a reduced rate (50% of annual licensing) to benchmark oocyte assessment accuracy against your embryologists' assessments before committing to full purchase. -
User-based vs. cycle-based pricing
If Fairtility offers flexible licensing (per embryologist, per cycle, or per clinic), model which structure minimizes cost for your throughput. High-volume clinics may favor per-cycle pricing; low-volume clinics may prefer per-user annual licenses. -
Inquire about research partnerships
Some AI vendors offer reduced pricing or free access to clinics that contribute data to published studies. If your clinic is equipped for prospective data collection, this may reduce costs while advancing clinical validation. -
Cross-compare incubator integrations
Obtain pricing quotes for CHLOE OQ bundled with MIRI (Esco), Embryoscope (Vitrolife), and Geri (Cooper). One partnership may offer substantially better terms.
When the price feels off — red flags
-
No SLA or uptime guarantee in the contract
Cloud-based software should include 99.5%+ uptime guarantees and documented incident response times. Insist on this in writing. -
Vendor refuses to disclose total cost of ownership (TCO)
If Fairtility will not itemize licensing, support, integration, and training costs, escalate to a contracting officer or demand transparency in writing. -
Lock-in without data portability
Confirm your oocyte image data and assessment reports are exportable in standard formats (DICOM, PDF, CSV). Avoid contracts that make data hostage to the platform. -
Unclear upgrade path to FDA approval
CHLOE portions are "pending FDA approval." Clarify: Will approved modules increase cost? Will you be billed for re-validation? Will older licensing become obsolete? -
No training or support included for base price
If the quoted price excludes on-site training, EMR integration support, or a dedicated account manager, confirm these costs separately before final approval. -
"Unlimited cycles" claims without performance metrics
Verify that "unlimited use" actually means zero per-cycle charges. Request historical data on per-cycle processing time and accuracy.
Sources
- Fairtility. CHLOE OQ: Oocyte Quality Insights. Retrieved January 2026. https://fairtility.com/chloe-oq-for-egg-freezing-2/
- Esco Medical. MIRI Time-Lapse Incubator with Fairtility CHLOE EQ. Retrieved January 2026. https://www.esco-medical.com/news/esco-medical-selects-fairtilitys-chloe-eq-as-ai-decision-support-tool-for-miri-time-lapse-incubators
- Fairtility. FAQ. Retrieved January 2026. https://fairtility.com/faq/
- Yelke, H.K., et al. (2022). Simplifying the complexity of time-lapse decisions with AI: CHLOE can automatically annotate morphokinetics and predict blastulation. ESHRE Annual Meeting, O-007. https://www.eshre.eu
- HRC Fertility. Geri Time-Lapse Incubator + CHLOE Analysis Tool. Retrieved January 2026. https://www.havingbabies.com/geri-time-lapse-imagery-incubator/
Article Status: Draft. Pricing data is non-existent in the public domain. MedSource will update this estimate as procurement quotes are collected from fertility clinics. Procurement officers with quotes are encouraged to contribute anonymized pricing data.
MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.